Takeda Pharmaceutical Company Limited (LON:0A87)

LON:0A87 Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	39,108	34,886	34,363	41,118	33,976	40,888
Market Cap Growth	16.84%	1.52%	-16.43%	21.02%	-16.91%	6.29%
Enterprise Value	61,629	60,410	60,110	66,084	56,723	71,294
Last Close Price	11.80	11.10	10.35	12.13	9.83	11.92
PE Ratio	73.08	62.54	45.57	21.33	23.57	16.57
PS Ratio	1.85	1.47	1.54	1.68	1.52	1.95
PB Ratio	1.08	0.97	0.90	1.06	0.95	1.20
P/FCF Ratio	8.17	7.88	12.14	8.08	5.42	6.92
P/OCF Ratio	6.94	6.39	9.16	6.92	4.83	6.16
EV/Sales Ratio	2.92	2.55	2.69	2.70	2.54	3.40
EV/EBITDA Ratio	9.87	9.48	10.04	8.46	7.65	11.04
EV/EBIT Ratio	21.73	20.76	22.99	17.54	15.09	25.62
EV/FCF Ratio	12.87	13.65	21.23	12.99	9.06	12.07
Debt / Equity Ratio	0.71	0.73	0.75	0.77	0.85	0.98
Debt / EBITDA Ratio	4.09	3.96	4.57	3.79	4.07	5.16
Debt / FCF Ratio	5.37	5.94	10.10	5.81	4.81	5.64
Asset Turnover	0.29	0.31	0.29	0.30	0.27	0.25
Inventory Turnover	1.16	1.30	1.30	1.36	1.40	1.34
Quick Ratio	0.54	0.44	0.50	0.49	0.73	1.00
Current Ratio	1.19	1.01	1.11	0.97	1.21	1.53
Return on Equity (ROE)	1.50%	1.52%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	2.47%	2.40%	2.15%	2.85%	2.88%	2.06%
Return on Invested Capital (ROIC)	2.76%	2.91%	4.35%	5.15%	4.82%	4.50%
Return on Capital Employed (ROCE)	4.70%	4.80%	3.90%	5.40%	5.40%	3.80%
Earnings Yield	1.37%	1.60%	2.20%	4.69%	4.24%	6.04%
FCF Yield	12.25%	12.69%	8.24%	12.37%	18.44%	14.44%
Dividend Yield	2.70%	9.13%	9.51%	9.02%	11.48%	9.91%
Payout Ratio	277.04%	280.28%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-0.25%	-1.58%	-0.67%	0.46%	-0.23%	-0.47%
Total Shareholder Return	2.45%	7.54%	8.84%	9.49%	11.25%	9.44%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.